Our wide-ranging Contract R&D services are based on in-depth knowledge and hands on experience in process development of recombinant biotherapeutics from microbial and mammalian platforms including Monoclonal antibodies (mAbs). We offer strong analytical expertise in characterization of therapeutic proteins using a wide array of techniques, which translates into an efficient process and enhanced product quality.

The projects we undertake may be stand-alone activities or complete process development packages, as per the client’s requirement.